$112.26 +1.27 (%) Johnson & Johnson - New York Stock Exchange, Inc.

Dec. 9, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily | Dec. 8, 2016 | 15:39PM EST
  2. What Comes After The Trump Rally?

    TalkMarkets | Dec. 8, 2016 | 00:17AM EST
  3. Trump Vow On Drug Prices Hammers Drug Stocks, But Key Indexes Up

    Investors Business Daily | Dec. 7, 2016 | 12:12PM EST
  4. Dow, S&P 500 Go Positive As Stocks Pare Losses; Dave & Buster's Pops 14%

    Investors Business Daily | Dec. 7, 2016 | 10:33AM EST
  5. Sanofi May Battle Johnson & Johnson For European Biotech Actelion

    Investors Business Daily | Dec. 6, 2016 | 12:01PM EST
  6. Stocks Futures Edge Higher; Cook: Apple Watch Doing Just Fine

    Investors Business Daily | Dec. 6, 2016 | 07:54AM EST
  7. Johnson & Johnson (JNJ) To Pay $1B For Defective Hip Implants

    TalkMarkets | Dec. 5, 2016 | 10:28AM EST
  8. Juno Therapeutics (JUNO) Shows Positive Early Data In Leukemia Patients

    TalkMarkets | Dec. 5, 2016 | 09:21AM EST
  9. Merck & Co., Inc. Increases Dividend 2% & Has Several Key Growth Drivers

    TalkMarkets | Nov. 29, 2016 | 15:10PM EST
  10. Global Stocks Pressured As Oil Slides On OPEC Deal Concerns; US Futures, Dollar Rise

    TalkMarkets | Nov. 29, 2016 | 07:40AM EST
  11. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets | Nov. 28, 2016 | 11:59AM EST
  12. December 2016 Stock Considerations

    TalkMarkets | Nov. 28, 2016 | 10:06AM EST
  13. Overview of Fidelity Stock Selector Large Cap Value Fund (FSLVX)

    TalkMarkets | Nov. 27, 2016 | 14:22PM EST
  14. Johnson & Johnson Creeps Higher On Actelion Purchase

    TalkMarkets | Nov. 27, 2016 | 03:28AM EST
  15. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  16. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  17. Verizon Falls From Dow Top Spot

    TalkMarkets | Nov. 17, 2016 | 10:00AM EST
  18. Rollercoaster Post-Election

    TalkMarkets | Nov. 11, 2016 | 17:46PM EST
  19. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  20. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  21. Buy Health Care Now? It All Depends On The Election

    TalkMarkets | Nov. 7, 2016 | 01:10AM EST
  22. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  23. Enhancing Your Income Portfolio With Dividend Growth ETFs

    TalkMarkets | Nov. 4, 2016 | 01:00AM EST
  24. 5 Best Performing Stocks Of October

    TalkMarkets | Nov. 3, 2016 | 17:20PM EST
  25. Dividend Aristocrats In Focus Part 24: Johnson & Johnson

    TalkMarkets | Nov. 1, 2016 | 12:02PM EST
  26. Buy Johnson & Johnson If Hillary Prevails

    TalkMarkets | Nov. 1, 2016 | 09:57AM EST
  27. After 9 Months This Year, I’m Beating The Market

    TalkMarkets | Oct. 25, 2016 | 22:16PM EST
  28. Inflation And A High Pressure Economy

    TalkMarkets | Oct. 19, 2016 | 22:15PM EST
  29. J&J Outshines in Q3 Earnings on Strong Pharma Sales

    TalkMarkets | Oct. 18, 2016 | 11:01AM EST
  30. Setup Of The Week - Johnson & Johnson

    TalkMarkets | Oct. 17, 2016 | 17:31PM EST
  31. 5 Stocks To Watch Before The Market Opens Tomorrow (October 18, 2016)

    TalkMarkets | Oct. 17, 2016 | 16:12PM EST
  32. The Market Glance For October 17th: Will IBM Sing the Blues?

    Dividend.com | Oct. 17, 2016 | 09:00AM EST
  33. Dow Top-Ten List Remains Static

    TalkMarkets | Oct. 13, 2016 | 17:24PM EST
  34. A Guide To Conservative Income Producing Option Strategies For Dividend Stocks

    TalkMarkets | Oct. 13, 2016 | 13:01PM EST
  35. An Interview With Relmada Therapeutics

    TalkMarkets | Oct. 13, 2016 | 12:39PM EST
  36. Big Pharma’s Big Biotech Problem

    Dividend.com | Oct. 12, 2016 | 08:00AM EST
  37. Dividend Aristocrats In Focus Part 1: Consolidated Edison

    TalkMarkets | Oct. 11, 2016 | 13:08PM EST
  38. Weighing the Week Ahead: Is this the End of the “Earnings Recession?”

    TalkMarkets | Oct. 9, 2016 | 01:43AM EST
  39. Earnings ESP

    TalkMarkets | Oct. 8, 2016 | 18:11PM EST
  40. Week In Review: Teva Pays $160 Million For US/Canada Rights To Celltrion Biosimilars

    TalkMarkets | Oct. 8, 2016 | 13:30PM EST
  41. 5 Stock Picks Ahead Of World Mental Health Day

    TalkMarkets | Oct. 7, 2016 | 14:08PM EST
  42. Dow Jones Industrial Average Today Slips Ahead Of Friday Jobs Announcement

    TalkMarkets | Oct. 6, 2016 | 21:25PM EST
  43. What Rate Of Return Will An Investment In Johnson & Johnson Deliver?

    TalkMarkets | Oct. 6, 2016 | 05:00AM EST
  44. Valuation is a Measurement of Soundness and Not the Primary Total Return Producer

    TalkMarkets | Sep. 29, 2016 | 11:57AM EST
  45. The Last Chapter in a Big Pfizer Plan

    Dividend.com | Sep. 29, 2016 | 08:00AM EST
  46. J&J Finally Returning to Its Roots in Diversity?

    GuruFocus | Sep. 26, 2016 | 11:04AM EST
  47. Analyst Recommends Trump V. Clinton Stock Picks As First Debate Nears

    TalkMarkets | Sep. 25, 2016 | 18:09PM EST
  48. Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract

    TalkMarkets | Sep. 24, 2016 | 16:56PM EST
  49. Income Planning Using Altria

    TalkMarkets | Sep. 23, 2016 | 17:25PM EST
  50. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
Trading Center